Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
On Capitol Hill, even Biden’s most staunch allies are beginning to privately say that his time is up. We expect many more defections in the next few days if Biden doesn’t act first.

Inside the Biden watch. Plus, news on the Trump shooting investigation

Exit Stage Left: This is a room that’s not too hard to read. House Minority Leader Hakeem Jeffries, Senate Majority Leader Chuck Schumer, former Speaker Nancy Pelosi, dozens of rank-and-file Democrats and now former President Barack Obama have all sent up warning flares that President Joe Biden should end his reelection campaign.

Subscripion logo

You're seeing a preview of our Premium coverage. Read the full story by subscribing here.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.